SRPT · Forms 3, 4, 5
Insider trades at Sarepta Therapeutics, Inc.
No open-market insider buys or sells at Sarepta Therapeutics, Inc. in the last 90 days; 6 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Sarepta Therapeutics, Inc. (SRPT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ryan Ho-Yan Wong | Chief Financial Officer | Tax withholding | 13,272 | $22.22 | $295K | Form 4 | |
| Ian Michael Estepan | Chief Operating Officer | Tax withholding | 24,799 | $22.22 | $551K | Form 4 | |
| Cristin Rothfuss | EVP, General Counsel | Tax withholding | 22,025 | $22.22 | $489K | Form 4 | |
| Louise Rodino-Klapac | President, R&D and Tech Ops | Tax withholding | 21,423 | $22.22 | $476K | Form 4 | |
| Michael Severino | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| Michael Severino | Chief Executive Officer | Award | 756,104 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.